EPISODE · Jul 29, 2021 · 24 MIN
A conversation with Sarah Boyce, CEO of Avidity Biosciences
from MedCity Pivot · host Arundhati Parmar, Sarah Boyce
Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients. Episode Resources Connect with Arundhati Parmar [email protected] https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sarah Boyce https://www.linkedin.com/in/sarah-boyce-7775808/ http://www.aviditybiosciences.com/about-us/
Embed this episode
NOW PLAYING
A conversation with Sarah Boyce, CEO of Avidity Biosciences
No transcript for this episode yet
Similar Episodes
No similar episodes found.